The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5\;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseuodgene has been identified on chromosome 20. [provided by RefSeq, Mar 2012].
Gee, Zhang, Ashraf, Kohl, Sadowski, Vega-Warner, Zhou, Lovric, Fang, Nettleton, Zhu, Hoefele, Weber, Podracka, Boor, Fehrenbach, Innis, Washburn, Levy, Lifton, Otto, Han, Hildebrandt: "KANK deficiency leads to podocyte dysfunction and nephrotic syndrome." in: The Journal of clinical investigation, Vol. 125, Issue 6, pp. 2375-84, (2015) (PubMed).
Li, Kuo, Waterman, Kiyama, Moss, Vaughan: "Effects of brefeldin A-inhibited guanine nucleotide-exchange (BIG) 1 and KANK1 proteins on cell polarity and directed migration during wound healing." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Issue 48, pp. 19228-33, (2011) (PubMed).